Oncology
GenPath Oncology, a division of BioReference Health®, LLC is a leading expert in cancer diagnostics. GenPath offers a comprehensive test portfolio to provide a single-source solution laboratory to support the needs of healthcare providers and patients across all stages of cancer. Backed by a team of specialized board-certified pathologists, GenPath delivers a wide range of diagnostic oncology solutions, from routine clinical and special coagulation testing to complex genomic testing for tumor sequencing and hereditary cancer syndromes.
PATHOLOGY TESTING
GenPath testing processes are overseen by specialized board-certified pathologists in gastroenterology, genitourinary, surgical pathology, hematopathology, dermatopathology, and cytology.
HEMATOPATHOLOGY
GenPath can perform a comprehensive work-up for patients with hematopathologic tumors as well as special coagulation issues.
ONKOSIGHT ADVANCEDTM NEXT GENERATION SEQUENCING
OnkoSight AdvancedTM is a GenPath proprietary product line of Next-Generation Sequencing (NGS) assays for hematologic malignancies and solid tumors.
OnkoHRDTM
Measure genomic scars such as LOH, TAI, and LST in addition to sequencing of critical genes involved in the HRR pathway.
ONKOCLONETM MINIMAL RESIDUAL DISEASE MONITORING
Minimal residual disease (MRD) detection allows further refinement and individualization of treatment strategies for cancer patients.
ONKORISKTM HEREDITARY CANCER TESTING
GenPath’s new OnkoRiskTM panels have been carefully curated by oncologists, genetic counselors and geneticists simplifying test selection.
RESOURCES
Meet GenPath’s oncology experts and find additional clinical information.